EGFR and colorectal carcinoma: Interestingly, the direct cytotoxicity of CD64-CR T cells was significantly increased by treatment with cetuximab or the anti-B7-H3 antibody and by treatment with 376.96 mAb against EGFR-positive HCT116 cells and, to a lesser extent, against HT-29 CRC cells.